Between a Rock and a Hard Place: Percutaneous Aspiration and Debulking for Tricuspid Valve Endocarditis
Open Access
- 20 May 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25166
Abstract
Right-sided infective endocarditis (IE) constitutes about 10% of total IE cases. Of these, tricuspid endocarditis comprises about 90% of all right-sided IE cases with intravenous drug use (IVDU) as its strongest risk factor. In patients with larger vegetations (>20 mm) or with persistent bacteremia, surgical intervention is often the standard of care. With FDA approval in 2014 and limited cases with regards to its application in tricuspid endocarditis, AngioVac (AngioDynamics, Latham, NY) has been used as a less invasive, off-label, bridging agent for tricuspid IE treatment. We present a case of a 40-year-old man with a past medical history of IVDU who presented with tricuspid endocarditis. His blood cultures were positive for methicillin-susceptible Staphylococcus aureus bacteremia. A transthoracic echocardiogram showed a 2.7 x 1.1 cm vegetation of the tricuspid valve. The patient was thought to be a poor surgical candidate for multifactorial reasons including patient preference, hemodynamic instability, and a hospital course that was complicated by septic emboli and infectious glomerulonephritis. The patient was unable to clear blood cultures despite appropriate antibiotic therapy. He subsequently underwent an AngioVac procedure with removal of the vegetation from his tricuspid valve achieving adequate source control, clear blood cultures, and resolution of endocarditis. As this case illustrates, AngioVac should be considered an effective alternative to surgical intervention in tricuspid endocarditis. Further research and awareness of the utility of AngioVac in right-sided endocarditis are warranted and should be conducted.Keywords
This publication has 9 references indexed in Scilit:
- Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and TreatmentJournal of the American Heart Association, 2020
- AngioVac System Used for Vegetation Debulking in a Patient with Tricuspid Valve Endocarditis: A Case Report and Review of the LiteratureCase Reports in Cardiology, 2017
- A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno‐venous bypass: A single center experienceCatheterization and Cardiovascular Interventions, 2017
- Percutaneous Vacuum-Assisted Thrombectomy Device Used for Removal of Large Vegetations on Infected Pacemaker and Defibrillator Leads as an Adjunct to Lead ExtractionJournal of Atrial Fibrillation, 2016
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsCirculation, 2015
- Native valve right sided infective endocarditisEuropean Journal of Internal Medicine, 2013
- What size of vegetation is an indication for surgery in endocarditis?Interactive CardioVascular and Thoracic Surgery, 2012
- Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2009
- Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation sizeAmerican Heart Journal, 2005